Murugesan Palaniappan
Assistant Professor
Positions
- Assistant Professor
-
Pathology & Immunology
Center for Drug Discovery
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
- Group Leader
-
DNA encoded chemical library screening
Center for Drug Discovery
ÌÇÐÄÊÓÆµ of Medicine
- Member
-
Dan L Duncan Comprehensive Cancer Center
Education
- PhD from University of Madras
- Chennai, India
- Postdoctoral Training at University of Michigan
- Ann Arbor, Michigan, United States
Professional Interests
- Breast cancer
- DNA encoded chemical library screening
- Drug Discovery and Development
Websites
Selected Publications
-
Devakrishnan AK, Madasu C, Wang Y, Modukuri R, Bohren KM, MacKenzie KR, Young DW, Fuqua SAW, Matzuk MM and Palaniappan M. " " npj Breast Cancer. 2025 Nov 12; 125 (11) : 1-15.
-
Palaniappan M and Bohren KM.. " " J Steroid Biochem Mol Biol.. 2025 Jul ;
Pubmed PMID: . -
Palaniappan M. " " Biomedicines. 2024 Dec ; 12 (Estrogen for the Treatment and Prevention of Breast Cancer) : 1-17.
-
Palaniappan M*, Nguyen L, Grimm SL Xi Y, Xia Z, Li W, Coarfa C. " " PloS One. 2019 ;
Pubmed PMID: .
Memberships
- The Endocrine Society
- American Association for Cancer Research (AACR)
- Active Member
Funding
-
Development of Next-Generation Estrogen Receptor Mutant Inhibitors for Endocrine Resistant Metastatic Breast Cancer
#RP220524 - $769,179.00 (03/01/2022 - 02/28/2025)
- Grant funding from CPRIT
-
Development of a Precision Drug to target Y537S Mutant Estrogen Receptor in Metastatic Breast Cancer
#R03CA259664 - $160,000.00 (12/13/2021 - 11/30/2023)
- Grant funding from NIH/NCI
-
Developing Allosteric Small-Molecule Inhibitors of CDK6/Cyclin D to Overcome Resistance in Breast Cancer
#DBG-25-1434888-01-CCB - $297,000.00 (09/01/2025 - 08/31/2027)
- Grant funding from American Cancer Society
-
Breast SPORE Career Enhancement Program Award
- (08/01/2022 - 07/31/2023)
- Grant funding from NIH/NCI
Skills
- SCIENTIST
to edit your profile